Alan M Garber Receives Stock Award at Vertex Pharmaceuticals Inc MA (VRTX) — SEC Form 4, Oct 19, 2026

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Alan M Garber

Director

TXN 2026-10-15 · FILED 2026-10-19

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Vertex Pharmaceuticals Inc MA

VRTX CIK 0000875320

Reporting Owner

Name	Relationship
Alan M Garber CIK 0001312907	Director

Alan M Garber at Vertex Pharmaceuticals Inc MA Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Vertex Pharmaceuticals Inc MA

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Deferred Stock UnitsF1 F1 F1		2026-10-15	A - Award/Grant	29.272 A	$512.44		29.272 Common Stock	Direct

Footnotes (1)

F1: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Vertex Pharmaceuticals Inc MA

GET /v1/forms/4/0000875320-26-000274 API docs